Learn about INLYTA® (axitinib), an Rx option for the treatment of patients with advanced renal cell carcinoma (RCC). See risks & benefits.

INLYTA® (axitinib) Medication Guide PATIENT INFORMATION INLYTA® (in-ly-ta)(axitinib)tablets Important information: If your healthcare provider prescribes INLYTA for you to be taken with …

Oct 16, 2024 · Inlyta (axitinib) used to treat cancer of the kidney and is usually given after other cancer medication has been tried without successful treatment. Includes Inlyta side effects, interactions and …

Feb 28, 2025 · Common Brand Name (s): Inlyta Common Generic Name (s): axitinib Pronunciation: ax-I-ti-nib, in-ly-ta Drug Classes: kinase inhibitor Availability: prescription only; no generic available How …

Aug 1, 2024 · Inlyta (Axitinib) may treat, side effects, dosage, drug interactions, warnings, patient labeling, reviews, and related medications including drug comparison and health resources.

Feb 19, 2025 · These highlights do not include all the information needed to use INLYTA safely and effectively. See full prescribing information for INLYTA. INLYTA® (axitinib) tablets, for oral …

Aug 29, 2023 · Inlyta (axitinib) is a targeted anticancer medication that’s used for treating advanced kidney cancer (renal cell carcinoma). Depending on your situation, it can be taken by itself or …

See risks and benefits. Find info and resources for INLYTA®, an Rx option for the second-line treatment of advanced renal cell carcinoma (RCC) on the HCP site.

Treatment Name: Axitinib (Inlyta®) Axitinib (Inlyta®) is a Targeted Therapy for Renal Cell Carcinoma - Kidney Cancer How does axitinib work? Axitinib is designed to slow the growth of cancer cells by …

Jan 27, 2012 · Your Treatment Guide INLYTA® (axitinib) is a prescription medicine used to treat kidney cancer that has spread or cannot be removed by surgery (advanced renal cell carcinoma or RCC) …